Company profile: Capstan Therapeutics
1.1 - Company Overview
Company description
- Provider of in vivo mRNA and gene-editing therapeutics powered by its proprietary CellSeeker targeted lipid nanoparticle (tLNP) platform that uses protein binders such as antibodies to deliver mRNA or gene-editing tools to specific cell types. Offerings include CPTX2309, an in vivo CAR-T candidate for autoimmune disorders, immune-cell engineering via mRNA-encoded CARs, and gene-editing delivery to pathogenic cells.
Products and services
- TLNP platform: Custom-engineered targeted lipid nanoparticles conjugated with protein binders such as antibodies deliver mRNA or gene-editing tools in vivo to reprogram specific cell types, including CAR-T cells
- CPTX2309: In vivo CAR-T candidate for autoimmune disorders using targeted lipid nanoparticles to deliver mRNA encoding an anti-CD19 CAR specifically to CD8-expressing T cells
- Engineering of immune cells: Precision-targeted delivery of mRNA-encoded CARs to specific immune cells enables them to identify and eliminate pathogenic cells.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Capstan Therapeutics
CytoSolv
HQ: United States
Website
- Description: Provider of wound care technology focused on the treatment of diabetic ulcers and other wounds, developing solutions aimed at curing diabetic ulcers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoSolv company profile →
StemVax Therapeutics
HQ: United States
Website
- Description: Provider of novel immunotherapies for brain tumor patients, developing immunotherapeutic approaches to treat Glioblastoma Multiforme.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StemVax Therapeutics company profile →
OrthoSera
HQ: Austria
Website
- Description: Provider of serum-based orthobiologics and regenerative medicine products leveraging blood serum and plasma. Markets coating technology for human dental bone grafts. Offerings include BoneAlbumin, a serum albumin-coated bone allograft for bone regeneration, Vérplazma derived from blood plasma, and Hiperakut szérum, a hyperacute serum for regenerative applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OrthoSera company profile →
Histogenics
HQ: United States
Website
- Description: Provider of tissue regeneration treatments for long-lasting joint repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Histogenics company profile →
Cellular Biomedicine Group
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical development focused on immunotherapies for cancers and stem cell therapies for degenerative diseases, utilizing proprietary cell therapy technologies built on thirty years of research and human treatment experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellular Biomedicine Group company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Capstan Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Capstan Therapeutics
2.2 - Growth funds investing in similar companies to Capstan Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Capstan Therapeutics
4.2 - Public trading comparable groups for Capstan Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →